Keith Quirolo

1.1k total citations
31 papers, 818 citations indexed

About

Keith Quirolo is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Keith Quirolo has authored 31 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 23 papers in Hematology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Keith Quirolo's work include Hemoglobinopathies and Related Disorders (30 papers), Iron Metabolism and Disorders (18 papers) and Blood groups and transfusion (10 papers). Keith Quirolo is often cited by papers focused on Hemoglobinopathies and Related Disorders (30 papers), Iron Metabolism and Disorders (18 papers) and Blood groups and transfusion (10 papers). Keith Quirolo collaborates with scholars based in United States, Germany and Netherlands. Keith Quirolo's co-authors include Elliott Vichinsky, Marsha Treadwell, Lynne Neumayr, Paul Harmatz, Sylvia T. Singer, Thomas P. Moyer, Linda D. Ferrell, Daniel W. Golden, Roger A. Williams and Ellen Butensky and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and Pediatric Research.

In The Last Decade

Keith Quirolo

30 papers receiving 785 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Quirolo United States 15 704 607 193 139 50 31 818
Darcy Brodecki United States 8 447 0.6× 306 0.5× 222 1.2× 41 0.3× 6 0.1× 15 559
India Sisler United States 11 320 0.5× 321 0.5× 112 0.6× 7 0.1× 56 1.1× 37 523
Dolunay Gürses Türkiye 12 68 0.1× 105 0.2× 49 0.3× 28 0.2× 50 1.0× 45 400
Brent E. Finley United States 10 81 0.1× 141 0.2× 76 0.4× 20 0.1× 53 1.1× 18 394
A. Antsaklis Greece 15 35 0.0× 45 0.1× 242 1.3× 67 0.5× 43 0.9× 45 736
Rafael Jiménez Costa Rica 5 111 0.2× 236 0.4× 102 0.5× 17 0.1× 205 4.1× 8 456
Nedim Samancı Türkiye 11 22 0.0× 71 0.1× 76 0.4× 100 0.7× 12 0.2× 30 300
Doris A. Howell United States 10 42 0.1× 85 0.1× 19 0.1× 34 0.2× 14 0.3× 22 339
Ahmad A. Al Omar Saudi Arabia 10 57 0.1× 34 0.1× 120 0.6× 38 0.3× 131 2.6× 12 457
Charlotte F.J. Van Tuijn Netherlands 9 205 0.3× 159 0.3× 79 0.4× 17 0.1× 1 0.0× 20 290

Countries citing papers authored by Keith Quirolo

Since Specialization
Citations

This map shows the geographic impact of Keith Quirolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Quirolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Quirolo more than expected).

Fields of papers citing papers by Keith Quirolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Quirolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Quirolo. The network helps show where Keith Quirolo may publish in the future.

Co-authorship network of co-authors of Keith Quirolo

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Quirolo. A scholar is included among the top collaborators of Keith Quirolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Quirolo. Keith Quirolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Quirolo, Keith, et al.. (2014). The evaluation of a new apheresis device for automated red blood cell exchange procedures in patients with sickle cell disease. Transfusion. 55(4). 775–781. 18 indexed citations
2.
Agrawal, Anurag K., et al.. (2011). Red blood cell transfusion in pediatric patients with severe chronic anemia: How slow is necessary?. Pediatric Blood & Cancer. 58(3). 466–468. 11 indexed citations
3.
Quirolo, Keith. (2010). How do I transfuse patients with sickle cell disease?. Transfusion. 50(9). 1881–1886. 10 indexed citations
4.
Quirolo, Keith, et al.. (2010). Novel influenza a (H1N1) viral infection in pediatric patients with sickle‐cell disease. Pediatric Blood & Cancer. 56(1). 95–98. 8 indexed citations
5.
Treadwell, Marsha, Abbey Alkon, Keith Quirolo, & W. Thomas Boyce. (2010). Stress Reactivity as a Moderator of Family Stress, Physical and Mental Health, and Functional Impairment for Children With Sickle Cell Disease. Journal of Developmental & Behavioral Pediatrics. 31(6). 491–497. 17 indexed citations
6.
Neumayr, Lynne, Steven Pringle, Stephen Giles, et al.. (2010). Chart Card: Feasibility of a Tool for Improving Emergency Department Care in Sickle Cell Disease. Journal of the National Medical Association. 102(11). 1017–1024. 5 indexed citations
7.
Quirolo, Keith, et al.. (2009). Current issues in blood transfusion for sickle cell disease. Current Opinion in Pediatrics. 21(1). 15–21. 70 indexed citations
8.
Pakbaz, Zahra, et al.. (2005). Quality of Life in Patients with Thalassemia Intermedia Compared to Thalassemia Major. Annals of the New York Academy of Sciences. 1054(1). 457–461. 86 indexed citations
9.
Walters, Mark C., et al.. (2005). Sibling Donor Cord Blood Transplantation for Thalassemia Major: Experience of the Sibling Donor Cord Blood Program. Annals of the New York Academy of Sciences. 1054(1). 206–213. 33 indexed citations
10.
Walters, Mark C., et al.. (2005). Outcomes of Preimplantation Genetic Diagnosis Therapy in Treatment of β‐Thalassemia: A Retrospective Analysis. Annals of the New York Academy of Sciences. 1054(1). 500–503. 14 indexed citations
11.
Pearson, Sarah, Abbey Alkon, Marsha Treadwell, et al.. (2005). Autonomic reactivity and clinical severity in children with sickle cell disease. Clinical Autonomic Research. 15(6). 400–407. 56 indexed citations
12.
Pakbaz, Zahra, Roland A. Fischer, Marsha Treadwell, et al.. (2005). A Simple Model to Assess and Improve Adherence to Iron Chelation Therapy with Deferoxamine in Patients with Thalassemia. Annals of the New York Academy of Sciences. 1054(1). 486–491. 15 indexed citations
13.
Pakbaz, Zahra, et al.. (2005). Quality of Life (QOL) in Sickle Cell Disease (SCD).. Blood. 106(11). 1324–1324. 1 indexed citations
14.
Treadwell, Marsha, Amy Law, Jennifer Sung, et al.. (2004). Barriers to adherence of deferoxamine usage in sickle cell disease. Pediatric Blood & Cancer. 44(5). 500–507. 44 indexed citations
15.
Pakbaz, Zahra, Roland A. Fischer, Keith Quirolo, et al.. (2004). Assessing Compliance to Iron Chelation Therapy in Patients with Thalassemia.. Blood. 104(11). 3787–3787. 3 indexed citations
16.
Hoppe, Carolyn, et al.. (2000). Use of Hydroxyurea in Children Ages 2 to 5 Years With Sickle Cell Disease. ˜The œAmerican journal of pediatric hematology/oncology. 22(4). 330–334. 40 indexed citations
17.
Singer, Sylvia T., et al.. (2000). Changing Outcome of Homozygous α-Thalassemia: Cautious Optimism. ˜The œAmerican journal of pediatric hematology/oncology. 22(6). 539–542. 42 indexed citations
18.
Harmatz, Paul, Melvin B. Heyman, John T. Cunningham, et al.. (1999). Effects of Red Blood Cell Transfusion on Resting Energy Expenditure in Adolescents with Sickle Cell Anemia. Journal of Pediatric Gastroenterology and Nutrition. 29(2). 127–131. 9 indexed citations
19.
20.
Hoppe, Carolyn, et al.. (1999). The Safety and Efficacy of Hydroxyurea in 2 to 5 Year Old Children with Sickle Cell Disease. Pediatric Research. 45(4, Part 2 of 2). 147A–147A. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Darcy Brodecki Breakdown of academic impact, for papers by India Sisler Breakdown of academic impact, for papers by Dolunay Gürses Breakdown of academic impact, for papers by Brent E. Finley Breakdown of academic impact, for papers by A. Antsaklis Breakdown of academic impact, for papers by Rafael Jiménez Breakdown of academic impact, for papers by Nedim Samancı Breakdown of academic impact, for papers by Doris A. Howell Breakdown of academic impact, for papers by Ahmad A. Al Omar Breakdown of academic impact, for papers by Charlotte F.J. Van Tuijn
Rankless by CCL
2026